LongoVital® in the treatment of Sjogren's syndrome

Clinical and Experimental Rheumatology

Volumn 17, Issue 5, 1999, Pages 533-538

  Pedersen, A ^a   Gerner, N ^b   Palmvang, I ^b   Hoier Madsen M ^c  

^a BISPEBJERG HOSPITAL   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Herbs; Immunomodulation; LongoVital; Nutritional supplementation; Prophylaxis; Sjogren's syndrome; Vitamins

Indexed keywords

HERBACEOUS AGENT; LONGOVITAL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; IMMUNOGLOBULIN M; VITAMIN;

ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PHYTOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SJOEGREN SYNDROME; VITAMIN INTAKE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; BLOOD; CROSSOVER PROCEDURE; DRUG EFFECT; IMMUNOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PHYTOTHERAPY; SJOGREN'S SYNDROME; TREATMENT OUTCOME; VITAMINS;

EID: 0032589632     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. PEDERSEN A, HOUGEN HP, KLAUSEN B, WINTHER K: LongoVital in the prevention of recurrent aphthous ulceration. J Oral Pathol Med 1990; 19: 371-5.
2. PEDERSEN A, KLAUSEN B, HOUGEN HP, RYDER L, WINTHER K: Imunomodulation by LongoVital in patients with recurrent aphthous ulceration. J Oral Pathol Med 1990;19:376-80.
3. OXHOLM P: Primary Sjögren's syndrome - Clinical and laboratory markers of disease activity. Semin Arthritis Rheum 1992; 22: 114-26.
4. VITALI C, BOMBARDIERI S, MOUTSOPOULOSHM et al.: Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993; 36: 340-7.
5. DAWES C: Rhythms in salivary flow rate and composition. Int J Chronobiol 1974; 2: 253-79.
6. HUMBEL RL: Detection of antinuclear antibodies by immunofluorescence. In VAN VENROIJ WJ, MAINI RN (Eds.): Manual of Biological Markers of Disease. Dordrecht, Kluwer Academic Publishers, 1993: 1-16.
7. HØIER-MADSEN M, NIELSEN LP, MØLLER S: Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA). Ugeskr Læger 1986; 148: 2018-21.
8. FOX PC, ATKINSON JC, MACYNSKI AA et al.: Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991; 151: 1149-52;
9. RHODUS NL: Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome. Oral Dis 1997; 3: 93-8.
10. PASCHIDES CA, KITSIOS G, KARAKOSTAS KX, PSJLLAS C, MOUTSOPOULOS HM: Evaluation of tear break-up time, Schirmer's-I test and Rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol 1989; 7: 155-7.
11. PRAUSE JU: Clinical ophthalmological tests for the diagnosis of keratoconjunctivitis sicca. Clin Exp Rheumatol 1989; 7: 141-4.
12. BJERRUM KB: Tests and symptoms in kerato-conjunctivitis sicca and their correlation. Acta Ophthalmol Scand 1996; 74: 436-41.
13. FROST-LARSEN K, ISAOER H, MANTHORPE R: Sjögren's syndrome treated with bromhexine: A randomized clinical study. Br Med J 1978; 1: 1579-81.
14. MANTHORPE R, FROST-LARSEN K, HØJ L, ISAGER H, PRAUSE JU: Bromhexine treatment of Sjögren's syndrome: Effect on lacrimal and salivary secretion, and on proteins in tear fluid and saliva. Scand J Rheumatol 1981; 10: 177-80.
15. MANTHORPE R, HAGEN PETERSEN S, PRAUSE JU: Primary Sjögren's syndrome treated with Efamol/Efavit. A double-blind cross-over investigation. Rheumatol Int 1984;4:165-7.
16. PRAUSE JU, FROST-LARSEN K, HØJ L, ISAGER H, MANTHORPE R: Lacrimal and salivary secretion in Sjögren's syndrome: The effect of systemic treatment with bromhexine. Acta Ophthalmol 1984; 62: 489-97.
17. KRIEGBAUM NJ, VON LINSTOW M, OXHOLM P, PRAUSE JU: A follow-up study of the progress of keratoconjunctivitis sicca and response to treatment in primary Sjögren's syndrome. Scand J Rheumatol 1989; 18: 193-6.
18. MALE D, COOKE A, OWEN M, TROWSDALE J, CHAMPION B: Immunological effector systems. Complement. In MALE D, COOKE A, OWEN M, TROWSDALE J, CHAMPION B (Eds.): Advanced Immunology, 3rd ed., London etc., Mosby 1996: 13.1-16.
19. MAURY CPJ, TÖRNROTH T, TEPPO A-M: Atrophic gastritis in Sjögren's syndrome. Arthritis Rheum 1985; 28: 388-94.
20. RHODUS NL: Qualitative nutritional intake analysis of older adults with Sjögren's syndrome. Gerodontology 1988; 7: 61-9.